Cargando…
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
OBJECTIVE: The objective was to measure the efficacy of the vaccination regimen FFM ME-TRAP in preventing episodes of clinical malaria among children in a malaria endemic area. FFM ME-TRAP is sequential immunisation with two attenuated poxvirus vectors (FP9 and modified vaccinia virus Ankara), which...
Autores principales: | Bejon, Philip, Mwacharo, Jedidah, Kai, Oscar, Mwangi, Tabitha, Milligan, Paul, Todryk, Stephen, Keating, Sheila, Lang, Trudie, Lowe, Brett, Gikonyo, Caroline, Molyneux, Catherine, Fegan, Greg, Gilbert, Sarah C, Peshu, Norbert, Marsh, Kevin, Hill, Adrian V. S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1617125/ https://www.ncbi.nlm.nih.gov/pubmed/17053830 http://dx.doi.org/10.1371/journal.pctr.0010029 |
Ejemplares similares
-
Extended Follow-Up Following a Phase 2b Randomized Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
por: Bejon, Philip, et al.
Publicado: (2007) -
Immunogenicity of ChAd63 + MVA ME-TRAP in Senegalese adults
por: Mensah, Victorine, et al.
Publicado: (2014) -
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
por: Afolabi, Muhammed O, et al.
Publicado: (2016) -
A Randomised, Double-Blind, Controlled Vaccine Efficacy Trial of DNA/MVA ME-TRAP Against Malaria Infection in Gambian Adults
por: Moorthy, Vasee S, et al.
Publicado: (2004) -
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
por: Ogwang, Caroline, et al.
Publicado: (2013)